To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: EMEA Restricts Use of Oral Norfloxacin Drugs in UTIs URL: http://www.pslgroup.com/dg/2264FA.htm Doctor's Guide July 24, 2008
LONDON -- July 24, 2008 -- The European Medicines Agency has recommended restricting the use of oral norfloxacin-containing medicines in urinary infections. The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the marketing authorisations for oral norfloxacin-containing medicines, when used in the treatment of acute or chronic complicated pyelonephritis, should be withdrawn because the benefits of these medicines do not outweigh their risks in this indication. This is based on the fact that the efficacy has not been adequately demonstrated for this type of infection. The CHMP review of norfloxacin medicines was initiated on the request of the Belgian medicines regulatory agency. They questioned the efficacy of oral formulations of the medicine for complicated pyelonephritis in comparison with other fluoroquinolones. Following evaluation of information provided by the companies, the CHMP, at its July 2008 meeting, noted that there was not enough clinical data to demonstrate the efficacy of oral treatment with norfloxacin-containing medicines in complicated pyelonephritis. Therefore, the CHMP concluded that the use of oral norfloxacin-containing medicines in the treatment of acute or chronic complicated pyelonephritis could no longer be supported. The recommendation of the CHMP does not have an impact on the use of oral norfloxacin-containing medicines in other types of infection. Doctors should not prescribe oral norfloxacin for complicated pyelonephritis and should consider switching patients already taking oral norfloxacin for this type of infection to an alternative antibiotic. SOURCE: The European Medicines Agency --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.